NASDAQ: LFCRLifecore Biomedical Revenue
Lifecore Biomedical revenue was $132.88M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $34.2M, up 47.3% from last quarter. For the last reported fiscal year 2025 ending May 25, 2025, LFCR annual revenue was $128.9M, with 0.5% growth year-over-year.
LFCR past revenue growth
How has LFCR's revenue growth performed historically?
Company
3.11%
Industry
48.64%
Market
35.12%
LFCR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LFCR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LFCR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
LFCR revenue history
Current Revenue
$132.9M
Current Earnings
-$43.2M
Current Profit Margin
-32.5%
Be the first to know when LFCR announces revenue.
LFCR Revenue History By Year
| LFCR Yearly Revenue | LFCR Revenue | LFCR Change | LFCR Revenue Growth |
|---|---|---|---|
| 2025-05-25 | $128.87M | $606.00k | +0.47% |
| 2024-05-26 | $128.26M | $24.99M | +24.20% |
| 2023-05-28 | $103.27M | -$8.00M | -7.19% |
| 2022-05-29 | $111.27M | $10.40M | +10.31% |
| 2021-05-30 | $100.87M | -$59.19M | -36.98% |
| 2020-05-31 | $160.07M | -$397.49M | -71.29% |
| 2019-05-26 | $557.56M | $33.33M | +6.36% |
| 2018-05-27 | $524.23M | $54.45M | +11.59% |
| 2017-05-28 | $469.78M | -$7.14M | -1.50% |
| 2016-05-29 | $476.92M | -$62.34M | -11.56% |
| 2015-05-31 | $539.26M | $62.44M | +13.10% |
| 2014-05-25 | $476.81M | $35.11M | +7.95% |
| 2013-05-26 | $441.71M | $124.16M | +39.10% |
| 2012-05-27 | $317.55M | $40.82M | +14.75% |
| 2011-05-29 | $276.73M | $38.51M | +16.16% |
| 2010-05-30 | $238.22M | $2.29M | +0.97% |
| 2009-05-31 | $235.94M | -$2.59M | -1.09% |
| 2008-05-25 | $238.53M | $28.03M | +13.32% |
| 2007-05-27 | $210.50M | -$21.46M | -9.25% |
| 2006-05-28 | $231.95M | $26.72M | +13.02% |
| 2005-05-29 | $205.23M | $13.14M | +6.84% |
| 2004-05-30 | $192.09M | N/A | N/A |
| 2002-10-27 | $183.16M | -$7.49M | -3.93% |
| 2001-10-28 | $190.65M | -$6.58M | -3.34% |
| 2000-10-29 | $197.23M | $175.78M | +819.64% |
| 1999-10-31 | $21.45M | -$12.07M | -36.01% |
| 1998-10-31 | $33.52M | $24.00M | +252.21% |
| 1997-10-31 | $9.52M | $7.45M | +360.38% |
| 1996-10-31 | $2.07M | -$1.39M | -40.26% |
| 1995-10-31 | $3.46M | $1.76M | +103.53% |
| 1994-10-31 | $1.70M | $529.00k | +45.18% |
| 1993-10-31 | $1.17M | N/A | N/A |
Lifecore Biomedical Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.